|
INbank™
INbank™ links meticulously collected and broadly consented biological samples with real time health information to create a unique and powerful resource for discovery and validation research. In addition to comprehensive demographic, epidemiologic and clinical information collected from the subject at the time the biological samples are collected, additional retrospective and prospective information on study subjects can be obtained from information available for research purposes in the Indiana Network for Patient Care (INPC), the nation's first regional health information exchange. Created in 1994 by the Regenstrief Institute, Inc., the INPC includes clinical data from over 40 hospitals, public health departments, laboratories, imaging centers, and large group practices across Indiana as well as data gathered from commercial payors and medication usage data for INPC patients from Surescripts, the country's largest prescribing network.
Key Features of INbank™ include:
- Use of the Central Indiana population, an ethnically diverse community with a stable residency
- Non-overlapping study cohorts to increase the number of unique subjects
- Collection of DNA, RNA, plasma, serum, and urine under standardized protocols
- Processing of all biological samples under GLP conditions
- Storage and tracking of all biological samples under GSP
- Documented clinical diagnosis
- Age, gender and ethnicity/race matched cases and controls
- Subject consent for broad research use of both biological samples and data
- Subject consent for prospective longitudinal follow up via data available for research purposes in the INPC
- Comprehensive baseline epidemiologic, demographic and clinical information
- Medication history that includes prescription drug dose, frequency, length of treatment and adverse drug reactions, OTC medications and diet supplements
- Results of lab tests during treatment through data available for study purposes in the INPC
- Secure data management by the Regenstrief Institute, Inc.
|
|
